Correlation Between Neumora Therapeutics, and Arhaus

Can any of the company-specific risk be diversified away by investing in both Neumora Therapeutics, and Arhaus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neumora Therapeutics, and Arhaus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neumora Therapeutics, Common and Arhaus Inc, you can compare the effects of market volatilities on Neumora Therapeutics, and Arhaus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neumora Therapeutics, with a short position of Arhaus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neumora Therapeutics, and Arhaus.

Diversification Opportunities for Neumora Therapeutics, and Arhaus

-0.57

Correlation Coefficient

Neumora Therapeutics,  Arhaus

Excellent diversification

The 3 months correlation between Neumora and Arhaus is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Neumora Therapeutics, Common and Arhaus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arhaus Inc and Neumora Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neumora Therapeutics, Common are associated (or correlated) with Arhaus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arhaus Inc has no effect on the direction of Neumora Therapeutics, i.e., Neumora Therapeutics, and Arhaus go up and down completely randomly.

Pair Corralation between Neumora Therapeutics, and Arhaus

Given the investment horizon of 90 days Neumora Therapeutics, Common is expected to under-perform the Arhaus. In addition to that, Neumora Therapeutics, is 3.23 times more volatile than Arhaus Inc. It trades about -0.12 of its total potential returns per unit of risk. Arhaus Inc is currently generating about 0.16 per unit of volatility. If you would invest  878.00  in Arhaus Inc on October 25, 2024 and sell it today you would earn a total of  308.00  from holding Arhaus Inc or generate 35.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neumora Therapeutics, Common  vs.  Arhaus Inc

Neumora Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neumora Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Arhaus Inc

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Arhaus Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady technical indicators, Arhaus unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neumora Therapeutics, and Arhaus

The main advantage of trading using opposite Neumora Therapeutics, and Arhaus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neumora Therapeutics, position performs unexpectedly, Arhaus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arhaus will offset losses from the drop in Arhaus' long position.

The idea behind Neumora Therapeutics, Common and Arhaus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.